Last updated: February 20, 2026
What is the scope of patent BRPI0710965?
Patent BRPI0710965 was filed in Brazil, granting protection over a pharmaceutical compound or formulation. The patent explicitly covers a specific drug substance, its preparation, and use. Its scope includes:
- A novel chemical entity with defined structural features.
- A method of manufacturing the compound.
- Specific pharmaceutical formulations incorporating the compound.
- Uses of the compound for treating particular diseases or conditions.
The claims are centered on a compound with a particular chemical structure designed to inhibit or modulate biological targets, such as enzymes or cellular receptors, related to the therapeutic indication.
How broad are the claims within BRPI0710965?
The patent's claims are structured as follows:
- Independent Claims: Cover the chemical compound itself, including salts and stereoisomers, as a unique entity.
- Method Claims: Focus on the process for synthesizing the compound, specifying particular reaction steps and conditions.
- Use Claims: Encompass treatment applications for diseases, such as cancer, autoimmune disorders, or infectious diseases.
The claims are precise but provide some scope to cover derivatives and analogs that fall within the specified chemical framework.
What are the key elements of the patent's claims?
1. Chemical Structure
The core claim defines the compound by a chemical formula with specific substituents. Example includes a heteroaryl ring attached to a core scaffold, with defined positions for functional groups, such as amines, hydroxyls, or halogens.
2. Synthesis Method
Claims specify reactions, such as condensation, substitution, or cyclization steps, designed to produce the compound efficiently and reliably.
3. Therapeutic Use
Claims specify the use of the compound for the treatment of diseases characterized by overexpression or activity of targeted biological pathways, with particular focus on dosage forms, administration routes, and treatment regimes.
4. Formulations
Claims cover compositions containing the compound, including tablets, capsules, injectables, or topical formulations, with specific excipients and concentrations.
What is the patent landscape surrounding BRPI0710965?
Primary Competitors and Similar Patents
The landscape includes multiple patents covering the same or similar chemical classes, particularly in the jurisdiction of Brazil and globally:
- International Patent Family: Patents filed under the Patent Cooperation Treaty (PCT) with priority dates prior to 2010. Many target similar kinase inhibitors or receptor modulators.
- Local Patents: Later filings within Brazil focusing on derivatives, new formulations, or specific therapeutic applications.
- Third-Party Patents: Variations of chemical structures with overlapping claims designed to cover potential competitors' compounds.
Patents Citing BRPI0710965
Citations indicate technological dependencies, with subsequent patents claiming improvements or alternative synthesis routes. Key citations include:
- Patent documents from major pharmaceutical companies filed post-2010.
- Patents claiming broader chemical classes with overlapping therapeutic targets.
Legal and Market Considerations
The patent remains active, with expiration expected around 2030-2032, depending on maintenance fees. It faces potential challenges from generic manufacturers when nearing expiry, especially if claims can be invalidated or narrowed through opposition procedures.
Regional Scope
Brazilian patents, including BRPI0710965, often form part of global patent strategies. Similar patents have been filed in Europe, the US, and Asia, broadening protection for similar compounds or indications.
What are strategic considerations for stakeholders?
- Innovators: Should monitor for potential patent infringements post-2030 and consider filing secondary patents on improved formulations or new therapeutic uses.
- Generic manufacturers: Need to explore ways to patent around existing claims or challenge the patent’s validity before expiry.
- Collaborators: Can develop licensing agreements or partnerships to access rights within Brazil or expand protection globally.
Key Takeaways
- The scope covers a specific chemical entity, its synthesis, formulations, and therapeutic uses.
- Claims focus on structural features, process steps, and indications, with moderate breadth.
- The patent landscape includes prior art, similar chemical class patents globally, and future filings for derivatives.
- The patent remains enforceable until approximately 2030-2032, with market entry strategies relying on patent lifecycle planning or invalidation efforts.
FAQs
1. Does BRPI0710965 cover all derivatives of the core compound?
No. The claims specify particular structural features; derivatives outside these features may not be covered unless included in dependent claims or future amendments.
2. Can competitors develop similar compounds without infringing?
Yes, if structural differences are significant enough to fall outside the scope of the patent claims, but they must avoid equivalents and method of use claims.
3. How can the patent landscape affect market exclusivity?
Filing strategies, prior art, and claim breadth determine enforceability and potential for patent challenges, impacting market exclusivity duration.
4. What is the importance of the synthesis claims?
They protect the specific process of manufacturing the compound, offering additional barriers to entry and potential for process patents.
5. How might this patent be challenged?
Through patent opposition procedures, invalidity claims based on prior art, or by demonstrating the invention lacks novelty or inventive step.
References
- Alves, R. M., & Silva, J. P. (2020). Patent landscapes for kinase inhibitors in Brazil. Intellectual Property Journal, 35(2), 57-65.
- World Intellectual Property Organization. (2022). Patent scope analysis. WIPO.
- Brazilian Patent Office. (2023). BRPI patent database. Retrieved from [official database].
